Salivary 1,5-Anhydroglucitol in Type 2 Diabetes: Evidence, Assay Barriers, and Point-of-Care Readiness

Millions of adults around the world live with type 2 diabetes, a condition where the body struggles to manage blood sugar, yet a large portion of these individuals remain unaware they are sick. Detecting this disease early is vital to prevent serious complications, but the current tools for diagnosis often require a needle stick and a trip to a laboratory. Doctors typically rely on tests that measure blood sugar at a single moment or a marker called glycated hemoglobin, which acts like a long-term memory of blood sugar levels over the past few months. While these methods are reliable, they can miss short, sharp spikes in sugar that happen after meals, and the need for blood draws can be a barrier for many people. This gap has sparked interest in finding a way to check for diabetes without breaking the skin, using a fluid that is naturally produced in the mouth: saliva.

Saliva is a complex mixture that reflects what is happening throughout the body. Scientists have long known that when blood sugar gets too high, the kidneys stop reabsorbing a specific sugar-like substance called 1,5-anhydroglucitol, causing it to wash out of the body in urine. Because this substance is removed when sugar levels are high, its presence in the blood drops. The idea is that if this drop happens in the blood, it should also happen in the saliva, offering a noninvasive way to spot recent sugar spikes. If researchers could measure this substance in spit, dentists and community health workers might be able to screen for diabetes during routine visits, identifying people who need further medical attention before they develop severe symptoms.

A team of researchers from institutions in Chile, the United States, Germany, Iran, Malta, and the United Arab Emirates recently set out to review the current state of this idea. They did not conduct a new experiment with patients; instead, they gathered and analyzed every available study that had looked at 1,5-anhydroglucitol in the saliva of people with type 2 diabetes. Their goal was to determine if this approach is ready for real-world use or if it is still stuck in the laboratory phase. They examined eight primary studies that directly measured this substance in saliva, as well as several studies on new devices designed to test saliva for other diabetes-related markers.

The researchers found that the biological logic holds up: in the studies they reviewed, people with poorly controlled diabetes generally had lower levels of this substance in their saliva compared to healthy individuals. The levels tended to drop when blood sugar was high, mirroring what happens in the blood. However, the evidence is far from perfect. The studies they reviewed were small, often involving only a few dozen people, and were conducted in single locations. More importantly, the methods used to collect the saliva varied wildly from one study to the next. Some researchers asked people to spit into a cup, while others used swabs to rub the inside of the cheek. Some tests were done after fasting, while others were done after eating. Because of these differences, the numbers reported for what counts as a "normal" or "diabetic" level were inconsistent, making it impossible to set a universal standard that doctors could use today.

The review also looked at the technology needed to turn this concept into a simple test that a dentist could use at the chairside. While there are promising prototypes for devices that can detect glucose or other chemicals in saliva, none of the devices found in the literature were actually designed to measure 1,5-anhydroglucitol. The existing technology is mostly limited to complex laboratory equipment that requires expensive machines and skilled technicians to process the sample. There is no simple, portable kit available yet that can give an instant result in a dental office or a community clinic.

Despite these hurdles, the authors suggest that this approach is not dead, but rather needs more work before it can be used as a standalone diagnostic tool. They argue that the most realistic role for a saliva test in the near future is not to diagnose diabetes on its own, but to act as a screening signal. In this scenario, a dentist or community health worker could use a simple saliva test to identify patients who might have undetected diabetes. If the test shows low levels of the substance, it would serve as a flag to send that patient to a doctor for a confirmatory blood test. This would turn dental visits into opportunities for early detection, bridging the gap between oral health and overall health.

The researchers emphasize that for this to work, the scientific community must first agree on exactly how to collect and handle saliva samples to ensure the results are reliable. They also need to develop a test that can work in a messy environment like the mouth, where food particles, bacteria, and other chemicals could interfere with the measurement. Until these barriers are cleared and large-scale studies prove the method works across different populations, the idea remains a promising possibility rather than a medical reality. The path forward involves refining the collection process, building better sensors, and validating the results in real-world settings, ensuring that when the test finally arrives, it is accurate enough to change lives.